Placental aromatase expression decreased in severe neonatal opioid withdrawal syndrome by Courtney Townsel (6705368)

Hypoxia-induced increase in STAT5A substrate phosphorylation by prostate carcinoma cells. by Kathrine Røe (411861)

“…(C) Western blot of anti-phospho-STAT5A/B and anti-STAT5A expression in normoxic (−) and severely hypoxic (<0.02% O₂, 24 h) (+) cell lysates from PC3, DU145 and 22Rv1 cells. …”

Demographics and baseline comorbidities in the 365 days prior to first SARS-CoV-2 positive test among a SARS-CoV-2-positive cohort identified between February 29th, 2020 through De... by Shannon L. Reynolds (14822662)

Sum concentrations of POP groups analyzed in osprey eggs from different study areas on a logarithmic scale. by Matti Viluksela (321291)

Presentation1_Ligand-bound integrin αvβ6 internalisation and trafficking.pdf by Amelia Meecham (13301040)

“…<p>The integrin αvβ6 is expressed at low levels in most normal healthy tissue but is very often upregulated in a disease context including cancer and fibrosis. …”

Zebrafish TMEM33 decreases TBK1-mediated MITA phosphorylation. by Long-Feng Lu (6528632)

<i>shk-1</i> mutants display decreased glycogen storage. by Longjun Pu (20685717)

Characteristics of patients with AKI diagnosed using eKDIGO only by the decrease in sCr (deKDIGO) and no AKI. by Marina Wainstein (12437091)

Alcian blue staining and gross specimen after FGF injection in chronic vocal fold scar model of rabbit. by Myung Jin Ban (2941842)

Fluvastatin regulated AGE-induced cell cycle progression through an ERK5 activating pathway in VSMCs. by Ae-Rang Hwang (4040408)

Contains underlying data for Figs 1A, 1F, 1G, 1I, 1J, 2D, 2E, 2G, 2H, 2J, 2K, 2M, 2N, 3A, 3B, 3C, 3D, 3F, 4A, 4B, 4C, 4D, 4E, 5I, 6A, 6B, 6D, 6F, 7B, 7D, and 7F and S1A, S1B, S3A,... by Xiao Chen Shi (8611887)

Affective Disorders, Psychosis and Dementia in a Community Sample of Older Men with and without Parkinson’s Disease - Fig 1 by Osvaldo P. Almeida (95282)

The effect of Nrf2 siRNA on the ERK5 activation-mediated inhibition of AGE-induced VSMC proliferation. by Ae-Rang Hwang (4040408)

Fluvastatin inhibited AGEs-induced cell proliferation through the ERK5-Nrf2 pathway in VSMCs. by Ae-Rang Hwang (4040408)

Activation as a function of illness course. by Maggie M. Sweitzer (3167943)

Highest V1V2 IgG3 binding magnitude observed among ALVAC-HIV/AIDSVAX B/E only recipients. by LaTonya D. Williams (3140490)

TITAN thresholds and percentile estimates for benthic macroinvertebrate and diatom communities deemed to be sensitive decreasers or tolerant increasers. The thresholds represent the largest fsum <i>z</i> value in the main data analysis run (i.e., the median), whereas the 5^th and 95^th percentile change points are determined from 500 bootstrap replicate runs.... by Brent J. Bellinger (21156150)

“…<p>TITAN thresholds and percentile estimates for benthic macroinvertebrate and diatom communities deemed to be sensitive decreasers or tolerant increasers. The thresholds represent the largest fsum <i>z</i> value in the main data analysis run (i.e., the median), whereas the 5^th and 95^th percentile change points are determined from 500 bootstrap replicate runs. …”

The effect of Nrf2 siRNA on the ERK5 activation-mediated inhibition of AGE-induced cell cycle progression. by Ae-Rang Hwang (4040408)

Mutation numbers and types observed in NER and CLR mutants following irradiation with Cs-137. by Bettina Meier (274833)

Dose dependent mutation burden in wild-type and DNA repair mutants. by Bettina Meier (274833)